THE INTERSECTION OF TECHNOLOGY AND MEDICINE IN IMAGING

Dindayal Darunde*, Sandip Umare, Dr. Amol Badkhal, Dr. Ritesh Bathe, Dr. Dipak Bathe

Nuclear medicine and molecular imaging represent a transformative suite of diagnostic and therapeutic technologies within modern medicine, leveraging radiopharmaceuticals to provide insights into biological processes at the molecular level. These techniques, including Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT), facilitate early disease detection, precise treatment monitoring, and personalized medicine approaches across various clinical specialties such as oncology, cardiology, and neurology. While these modalities offer numerous advantages, including functional imaging and targeted therapy applications, they also face challenges related to radiation exposure, accessibility, and high costs. The integration of advanced imaging technologies, including hybrid modalities like PET/CT and PET/MRI, enhances diagnostic accuracy by merging anatomical and functional data. Ongoing research and development of novel radiotracers aim to further improve the specificity and utility of nuclear medicine, underscoring its potential for future applications in disease management and personalized healthcare.